Authors: CESKA R HORINEK A SOBRA J WEISGRABER KH INNERARITY T SLEZKA V

Citation: R. Ceska et al., FDB-100 - DIAGNOSIS, LABORATORY AND CLINICAL FINDINGS, POSSIBILITIES OF TREATMENT - EXPERIENCE FROM HOMOZYGOUS AND HETEROZYGOUS PATIENTS, Atherosclerosis, 134(1-2), 1997, pp. 110-111

Authors: OCKNER RK BASS NM YAMANAKA S INNERARITY T

Citation: Rk. Ockner et al., HEPATOCELLULAR DYSPLASIA AND CARCINOMA IN APOBEC-1 TRANSGENIC MICE - INCREASED EXPRESSION OF EXTRAMITOCHONDRIAL FATTY-ACID OXIDATION, Hepatology, 24(4), 1996, pp. 852-852

Authors: RAFFAI R MAURICE R WEISGRABER K INNERARITY T WANG XB MACKENZIE R HIRAMA T WATSON D RASSART E MILNE R

Citation: R. Raffai et al., MOLECULAR CHARACTERIZATION OF 2 MONOCLONAL-ANTIBODIES SPECIFIC FOR THE LDL RECEPTOR-BINDING SITE OF HUMAN APOLIPOPROTEIN-E, Journal of lipid research, 36(9), 1995, pp. 1905-1918

Authors: BUCALA R MITCHELL R ARNOLD K INNERARITY T VLASSARA H CERAMI A

Citation: R. Bucala et al., IDENTIFICATION OF THE MAJOR SITE OF APOLIPOPROTEIN-B MODIFICATION BY ADVANCED GLYCOSYLATION END-PRODUCTS BLOCKING UPTAKE BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR, The Journal of biological chemistry, 270(18), 1995, pp. 10828-10832

Authors: BUCALA R MITCHELL RA INNERARITY T CERAMI A VLASSARA H

Citation: R. Bucala et al., AGE-MODIFIED LDL (AGE-LDL) IS NOT TAKEN UP BY CELLULAR LDL RECEPTORS, Circulation, 88(4), 1993, pp. 181-181